Author Correction: An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy. - Naveed M; Batool Z; Aziz T; Javed K; Ali N; Rehman HM; Alharbi M; Alasmari AF; Alshammari A (Scientific reports, 2025)